Award
National Cancer Institute 5R01CA262213-04
Stem cell-derived exosomes to ameliorate chemobrain
Recipient
University of California, Irvine
Award Amount
$359,138.00
Ceiling
$359,138.00
Awarded
January 30, 2026
Identifier
5R01CA262213-04
Award for research on using stem cell-derived exosomes to mitigate chemobrain effects in cancer therapy patients, funded by the National Cancer Institute.
Description
Research project focused on neurocognitive effects of cancer therapy and potential therapeutic interventions using extracellular vesicles and miRNA, emphasizing safety, toxicity, and pharmacokinetics of therapy.